Stock Have a Latest Story: HealthEquity, Inc. (NASDAQ: HQY)

On Wednesday, HealthEquity, Inc. (NASDAQ: HQY) closed with gain/decline of -2.22% to $58.61. Recent traded volume was 158,765 shares versus to it an average volume of 1,169,690 shares. The company holds 62.72M shares outstanding and market cap of 4.139B.

HealthEquity, Inc. (HQY) recently reported financial results for its second quarter ended July 31, 2019.

Second quarter financial results

For the second quarter ended July 31, 2019, HealthEquity stated revenue of $86.6M, a raise of 22% contrast to $71.1M for the second quarter ended July 31, 2018. Revenue consisted of:

  • Service revenue of $26.3M, a raise of 5% contrast to Q2 FY19.
  • Custodial revenue of $43.6M, a raise of 42% contrast to Q2 FY19.
  • Interchange revenue of $16.7M, a raise of 8% contrast to Q2 FY19.

Net income was $19.4M for the second quarter ended July 31, 2019, contrast to $22.5M for the second quarter ended July 31, 2018.

Net income per diluted share was $0.30 for the second quarter ended July 31, 2019, contrast to $0.36 for the second quarter ended July 31, 2018.

Non-GAAP net income per diluted share was $0.45 for the second quarter ended July 31, 2019, contrast to $0.36 for the second quarter ended July 31, 2018.

Adjusted EBITDA was $40.6M for the second quarter ended July 31, 2019, a raise of 28% contrast to $31.8M for the second quarter ended July 31, 2018. Adjusted EBITDA was 47% of revenue for the second quarter ended July 31, 2019, contrast to 45% for the second quarter ended July 31, 2018.

As of July 31, 2019, we had $815.2M of cash and cash equivalents and no outstanding debt. This compares to $361.5M in cash and cash equivalents and no outstanding debt as of January 31, 2019.

Business outlook

We have updated the HealthEquity standalone outlook for the year ending January 31, 2020. We expect our revenue to be between $341M and $347M. Our outlook for net income is a range of $9M to $13M, resulting in a net income per diluted share range of $0.13 to $0.19. Our Adjusted EBITDA outlook is a range of $138M to $142M. We define Adjusted EBITDA as adjusted earnings before interest, taxes, depreciation and amortization, amortization of purchased intangible assets, stock-based compensation expense, integration and acquisition-related costs, unrealized gains and losses on marketable equity securities, and other certain non-operating items. We also expect our non-GAAP net income to be in a range between $76M and $80M. Our non-GAAP net income is calculated by adding back to net income amortization of purchased intangible assets, stock-based compensation expense, and integration and acquisition-related costs, net of an estimated statutory tax rate of 24%, subtracting the excess tax benefits Because of the adoption of Accounting Standards Update (“ASU”) 2016-09, and adjusting for unrealized gains and losses on marketable equity securities, net of an estimated statutory tax rate of 24%. Our non-GAAP net income outlook results in a non-GAAP net income per diluted share range between $1.10 to $1.16 (based on an estimated 69M weighted-average shares outstanding).

HQY return on assets ratio of the Company was 14.50% and return on equity ratio was 15.60% while its return on investment ratio was 15.90%. The stock as of last trading session moved 16.54% up from its 52 week low and was -42.30% behind its 52 week high.

Leave a Reply

Your email address will not be published. Required fields are marked *